Flavonoid-induced autophagy in hormone sensitive breast cancer cells

Fitoterapia

Volumn 80, Issue 6, 2009, Pages 327-332

  Brunelli, Elisa ^a   Pinton, Giulia ^a   Bellini, Paolo ^a   Minassi, Alberto ^a   Appendino, Giovanni ^a   Moro, Laura ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

8 Prenylapigenin; 8 Prenylnaringenin; Autophagy; Breast cancer cells; Cell signalling; Isocannflavin B

Indexed keywords

8 PRENYLAPIGENIN; CYCLIN DEPENDENT KINASE INHIBITOR 1; ESTROGEN; FLAVONOID; ISOCANNFLAVIN B; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ARTICLE; AUTOPHAGY; BREAST CANCER; CANCER CELL CULTURE; CELL PROLIFERATION; CELL VACUOLE; CONTROLLED STUDY; DRUG ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; AUTOPHAGY; BREAST NEOPLASMS; CANNABIS; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYTOPLASM; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTROGENS; FEMALE; FLAVANONES; FLAVONES; FLAVONOIDS; HUMANS; HUMULUS; PHOSPHORYLATION; PHYTOESTROGENS; PHYTOTHERAPY; PLANT EXTRACTS; PRENYLATION; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; VACUOLES;

EID: 67650450192     PISSN: 0367326X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fitote.2009.04.002     Document Type: Article

References (20)

1. Kitaoka M., Kadokawa H., Sugano M., Ichikawa K., Taki M., Takaishi S., et al. Prenylflavonoids: a new class of non-steroidal phytoestrogen (part 1). Isolation of 8-isopentenylnaringenin and an initial study on its structure-activity relationship. Planta Med 64 6 (1998) 511-515
2. Miyamoto M., Matsushita Y., Kiyokawa A., Fukuda C., Iijima Y., Sugano M., et al. Prenylflavonoids: a new class of non-steroidal phytoestrogen (part 2). Estrogenic effects of 8-isopentenylnaringenin on bone metabolism. Planta Med 64 6 (1998) 516-519
3. Milligan S.R., Kalita J.C., Pocock V., Van De Kauter V., Stevens J.F., Deinzer M.L., et al. Identification of a potent phytoestrogen in hops (Humus lupulus L.) and beer. J Clin Endocrinol Metabol 85 (2000) 4912-4915
4. Schaefer O., Huempel M., Fritzemeier K.H., Bohlmann R., and Schleuning W.D. 8-Prenylnaringenin is a potent ERalpha selective phytoestrogen present in hops and beer. J Steroid Biochem Mol Biol 84 (2003) 359-360
5. Matsumura A., Ghosh A., Pope G.S., and Darbre P.D. Comparative study of oestrogenic properties of eight phytoestrogens in MCF7 human breast cancer cells. J Steroid Biochem Mol Biol 94 5 (2005) 431-443
6. Marino M., Acconcia F., and Ascenzi P. Estrogen receptor signalling: bases for drug actions. Curr Drug Targets Immune Endocr Metabol Disord 5 3 (2005) 305-314
7. Acconcia F., and Kumar R. Signaling regulation of genomic and nongenomic functions of estrogen receptors. Cancer Lett 238 1 (2006) 1-14
8. Migliaccio A., Piccolo D., Castoria G., Di Domenico M., Bilancio A., Lombardi M., et al. Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor. EMBO J 17 7 (1998) 2008-2018
9. Castoria G., Migliaccio A., Bilancio A., Di Domenico M., de Falco A., Lombardi M., et al. PI3-kinase in concert with Src promotes the S-phase entry of estradiol-stimulated MCF-7 cells. EMBO J 20 21 (2001) 6050-6059
10. Brunelli E., Minassi A., Appendino G., and Moro L. 8-Prenylnaringenin, inhibits estrogen receptor-alpha mediated cell growth and induces apoptosis in MCF-7 breast cancer cells. J Steroid Biochem Mol Biol 107 3-5 (2007) 140-148
11. Brunelli E., Pinton G., Chianale F., Graziani A., Appendino G., and Moro L. 8-Prenylnaringenin inhibits epidermal growth factor-induced MCF-7 breast cancer cell proliferation by targeting phosphatidylinositol-3-OH kinase activity. J Steroid Biochem Mol Biol 113 3-5 (2009) 163-170
12. Minassi A., Giana A., Ech-Chahad A., and Appendino G. A regiodivergent synthesis of ring A C-prenylflavones. Org Lett 10 (2008) 2267-2270
13. Dong X., Fan Y., Yu L., and Hu Y. Synthesis of four natural prenylflavonoids and their estrogen-like activities. Arch Pharm 340 (2007) 372-376
14. Minassi A., Giana A., Ech-Chahad A., and Appendino G. A regiodivergent synthesis of ring A C-prenylflavones. Org Lett 10 (2008) 2267-2270
15. Biederbick A., Kern H.F., and Elsässer H.P. Monodansylcadaverine (MDC) is a specific in vivo marker for autophagic vacuoles. Eur J Cell Biol 66 1 (1995) 3-14
16. Zava D.T., Blen M., and Duwe G. Estrogenic activity of natural and synthetic estrogens in human breast cancer cells in culture. Environ Health Perspect 105 Suppl 3 (1997) 637-645
17. Zava D.T., and Duwe G. Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Nutr Cancer 27 1 (1997) 31-40
18. Sherr C.J., and Roberts J.M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13 (1999) 1501-1512
19. Fujiwara K., Daido S., Yamamoto A., Kobayashi R., Yokoyama T., Aoki H., et al. Pivotal role of the cyclin-dependent kinase inhibitor p21WAF1/CIP1 in apoptosis and autophagy. J Biol Chem 283 1 (2008) 388-397
20. Wang Y.A., Johnson S.K., Brown B.L., McCarragher L.M., Al-Sakkaf K., Royds J.A., et al. Enhanced anti-cancer effect of a phosphatidylinositol-3 kinase inhibitor and doxorubicin on human breast epithelial cell lines with different p53 and oestrogen receptor status. Int J Cancer 123 7 (2008) 1536-1544